Clinical trial
Thromboprophylaxis in Critically Ill Patients
NCT00437697 · Medical University of Vienna, Other · Terminated
Key facts
| NCT number | NCT00437697 |
|---|---|
| Title | Thromboprophylaxis in Critically Ill Patients |
| Official title | Thromboprophylaxis in Critically Ill Patients: a Prospective, Randomized Study Comparing Anti-Xa Activities Following Subcutaneous Administration of 5000 IU and 7500 IU Dalteparin |
| Lead sponsor | Medical University of Vienna, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Venous Thromboembolism |
| Intervention type | Drug |
| Interventions | dalteparin |
| Enrollment | 90 |
| Start date | Apr 1, 2003 |
| Completion | Apr 1, 2005 |
| First posted | Feb 21, 2007 |
| Last update posted | Feb 21, 2007 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: